
zzso immune complexes zzso are known to be present in cancer patients and are responsible for much of the zzso zzso zzso or zzso of these zzso zzso can reverse the zzso zzso A from zzso zzso has the unusual property of binding to zzso with high zzso Use of protein A as an zzso in zzso zzso affinity columns has resulted in zzso and zzso responses in zzso Our group developed a zzso trial to assess toxicity and zzso response with this zzso response modifier zzso Overall, zzso (21 of 87 zzso had objective tumor zzso including both partial responses zzso and less than zzso No complete responses zzso were zzso zzso were observed in acquired immune zzso syndrome zzso zzso zzso (six of 17 zzso two of 17 less than zzso overall, zzso breast zzso (five of 22 zzso three of 22 less than zzso overall response, zzso colon zzso (one zzso one less than zzso overall response, zzso and zzso cell lung zzso zzso of seven less than zzso The procedure was well tolerated and could be performed on an zzso zzso No adverse reaction was observed in 735 of zzso treatments zzso The most common adverse effect was an zzso syndrome consisting of fever and zzso zzso was present in zzso of the zzso There were no zzso zzso zzso zzso and zzso levels did not statistically change due to therapy in responding or zzso zzso zzso levels remained within the normal zzso Liver and zzso tests remained stable throughout the zzso In zzso protein A zzso of plasma is well tolerated in the zzso clinic, has demonstrated zzso activity in resistant solid tumors, and functions as a zzso response zzso 

